Humalog
NDC 54868-4381
Product Information
Humalog is a NDA-approved product labeled by Physicians Total Care, Inc.. Insulin lispro is used with a proper diet and exercise program to control high blood sugar in people with diabetes. It is supplied as a product. This product entry covers the primary NDC 54868-4381 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 54868-4381?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- INSULIN LISPRO (UNII: GFX7QIS1II)
- INSULIN LISPRO (UNII: GFX7QIS1II) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- PROTAMINE SULFATE (UNII: 0DE9724IHC)
- GLYCERIN (UNII: PDC6A3C0OX)
- SODIUM PHOSPHATE, DIBASIC (UNII: GR686LBA74)
- METACRESOL (UNII: GGO4Y809LO)
- ZINC (UNII: J41CSQ7QDS)
- PHENOL (UNII: 339NCG44TV)
- WATER (UNII: 059QF0KO0R)
- HYDROCHLORIC ACID (UNII: QTT17582CB)
- SODIUM HYDROXIDE (UNII: 55X04QC32I)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 259111 - insulin lispro protamine / insulin lispro 75/25 Injectable Suspension
- RxCUI: 259111 - insulin lispro 25 UNT/ML / insulin lispro protamine, human 75 UNT/ML Injectable Suspension
- RxCUI: 259111 - insulin analog, lispro mixed 75/25 100 UNT/ML Injectable Suspension
- RxCUI: 752388 - HumaLOG Mix 75/25 Injectable Suspension
- RxCUI: 752388 - insulin lispro 25 UNT/ML / insulin lispro protamine, human 75 UNT/ML Injectable Suspension [Humalog Mix]
* Please review the full disclaimer at the bottom of this page.